Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

As a world pandemic, COVID-19 has driven new priorities for science and technology cooperation. 

To help respond and promote international dialogue between universities and the R&D industry, academics of Oxford University initiated a series of science lectures jointly with Chinese research institutes, hospitals and venture capitals from June 2020, including topics in Population Medicine, Drug Development, Vaccine, Digital Health, Immunology, Chronic Disease and Technology Innovation.

We are pleased to be starting Series II with the 8th lecture on 16th September with a celebration of Chinese Academy of Medical Sciences' 100 anniversary, to exchange ideas between 2 universities who act as leaders in 2 countries on medical science. 


Time: September 16, 2021

Venue: Beijing, China

Online platform: zoom(

Meeting ID: 948 1384 2668

Passcode: 123456

Organizer: Oxford University, Chinese Academy of Medical Sciences, Institute of Applied Digital Health, Peking Union Medical College, National Academy of Science and Art


UK Time



Opening Remarks

Vice President of CAMS, Prof Jianwei WANG


Introduction of Oxford Science Lecture

Prof. Richard Hobbs


Technology Driven Partnership and Future

President of CAMS, Prof Chen WANG


Education Driven New Industry and New World

Prof. Louise Richardson


Panel: (1) This year, the Union Medical College has been established for a hundred years, Oxford has been 

established for more than 800 years. What are the challenges to medical education in different historical 

periods of modern medicine? What are the reforms and changes in the education of medical colleges and universities?

(2) under the background of COVID-19's rapid waging, global health is facing new challenges. 

What role does university play in promoting population health and what responsibilities should it undertake?

(3) what will the two universities do in scientific research and medical education in the face of the post epidemic era? 

How to promote the combination of public management and scientific research?

Chen WANG, Jianwei WANG, Richard Hobbs, Louise Richardson 


Online Group Photo

All speakers and audiences


Vice-chancellor Prof Louise Richardson

Professor Richard Hobbs




chen wang.png

Professor in respiratory and critical care medicine, chief physician,  academician of Chinese Academy of engineering. Vice President of Chinese Academy of Engineering, President of Beijing Union Medical College, Chinese Academy of Medical Sciences.


He has engaged in medical treatment, teaching and research in the fields of pulmonary embolism and pulmonary hypertension, respiratory failure and respiratory support technology, new respiratory infectious diseases, chronic obstructive pulmonary disease, tobacco disease and so on. He is good at the diagnosis and treatment of difficult respiratory diseases and critical diseases. We have made a number of innovations such as sequential mechanical ventilation, reduced thrombolytic therapy for pulmonary embolism, and confirming the efficacy of traditional Chinese medicine on influenza, and entered the international guidelines to guide and improve clinical practice. To clarify the disease burden, diagnosis and treatment of chronic obstructive pulmonary disease and asthma in China. It has undertaken more than 10 national and international important research projects. He has published more than 100 papers in international authoritative journals such as BMJLancet. 

He edited more than 10 monographs such as pulmonary embolism, respiratory support technology and national planning textbooks such as internal medicine and critical care medicine. He won the science and technology progress award of the ho Leung Ho Lee Foundation and the outstanding contribution award to tobacco control of the World Health Organization.

Professor Wang Jianwei

prof wang Jianwei.png

Vice president of Peking Union Medical College, Chinese Academy of Medical Sciences

He is mainly engaged in the research on the pathogenesis, prevention and treatment of important respiratory virus infection.  Executive director of 6th Council of Chinese Preventive Medicine Association and executive editor of biosafety & Health magazine.

He has successively undertaken nearly 20 national scientific research projects, published nearly 100 SCI papers as corresponding authors, and won 6 provincial and ministerial level and above scientific and technological awards.